Alison J. E. Green
National CJD Surveillance Unit
The University of Edinburgh
Edinburgh
UK
Name/email consistency: high
- CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Green, A., Sanchez-Juan, P., Ladogana, A., Cuadrado-Corrales, N., Sánchez-Valle, R., Mitrová, E., Stoeck, K., Sklaviadis, T., Kulczycki, J., Heinemann, U., Hess, K., Slivarichová, D., Saiz, A., Calero, M., Mellina, V., Knight, R., van Duijn, C.M., Zerr, I. Eur. J. Neurol. (2007)
- 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein. Green, A.J., Ramljak, S., Müller, W.E., Knight, R.S., Schröder, H.C. Neurosci. Lett. (2002)
- Biochemical investigations in patients with dementia. Green, A. Ann. Clin. Biochem. (2002)
- Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease. Green, A.J. Biochem. Soc. Trans. (2002)
- Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease. Green, A.J. Neuropathol. Appl. Neurobiol. (2002)
- Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. Green, A.J., Thompson, E.J., Stewart, G.E., Zeidler, M., McKenzie, J.M., MacLeod, M.A., Ironside, J.W., Will, R.G., Knight, R.S. J. Neurol. Neurosurg. Psychiatr. (2001)